Latest Period
Q1 2026
Security Snapshot
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) Institutional Ownership
CUSIP: 03152W109
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
297
Shares (Excl. Options)
331,789,683
Price
$14.46
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Symbol
- FOLD
- Shares outstanding
- 316,644,581
- Reported price per share
- $14.49
- Price from insider filings
- $14.49
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 331,789,683
- Total reported value
- $4,794,109,165
- Portfolio coverage rank
- 0.01%
- Share change
- +1,463,671
- Value change
- +$31,783,996
- Number of holders
- 297
Security identity
Issuer context
Latest holder snapshot
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share is tracked under CUSIP 03152W109.
- 297 institutions reported positions in Q1 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 333 to 297 between Q4 2025 and Q1 2026.
- Reported value moved from $4,570,432,958 to $4,794,109,165.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 297 institutions filings for Q1 2026.
Security key
03152W109
Latest holder period
Q1 2026
13F holders
297
13D/G owners
9
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03152W109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
FOLD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 7.4% | -21% | $171,198,846 | -$38,641,761 | 22,765,804 | -18% | BlackRock, Inc. | 31 Mar 2025 |
| UBS Group AG | 5.5% | $247,870,674 | 17,141,817 | UBS Group AG | 31 Mar 2026 | |||
| GOLDMAN SACHS GROUP INC | 5.3% | $242,670,074 | 16,782,163 | THE GOLDMAN SACHS GROUP, INC. | 31 Mar 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.2% | $236,433,103 | 16,350,837 | Vanguard Capital Management | 31 Mar 2026 | |||
| Avoro Capital Advisors LLC | 4.9% | -26% | $118,397,000 | -$43,143,000 | 15,025,000 | -27% | Avoro Capital Advisors LLC | 30 Sep 2025 |
| Redmile Group, LLC | 4.6% | $106,667,402 | 14,184,495 | Redmile Group, LLC | 31 Dec 2024 | |||
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3.4% | -36% | $151,763,799 | -$76,348,548 | 10,627,717 | -33% | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 31 Dec 2025 |
| PERCEPTIVE ADVISORS LLC | 2.4% | -66% | $43,290,927 | -$82,061,910 | 7,412,830 | -65% | Perceptive Advisors LLC | 30 Jun 2025 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.4% | -91% | $19,618,821 | -$386,818,454 | 1,373,867 | -95% | Wellington Management Group LLP | 31 Dec 2025 |
As of 31 Mar 2026, 297 institutional investors reported holding 331,789,683 shares of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD). This represents 105% of the company’s total 316,644,581 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
75%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | 33,879,048 | +4.2% | 0.01% | $489,891,036 |
| UBS Group AG | 5% | 15,957,913 | +171% | 0.04% | $230,751,422 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 14,023,557 | 0% | 0.01% | $202,780,634 |
| Pentwater Capital Management LP | 4.4% | 14,000,000 | +22% | 1.4% | $202,440,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.4% | 13,974,932 | 0% | 0.01% | $202,077,517 |
| STATE STREET CORP | 4.1% | 12,893,897 | -13% | 0.01% | $186,445,751 |
| GLAZER CAPITAL, LLC | 4% | 12,722,749 | +693% | 3.9% | $183,971,000 |
| FIL Ltd | 4% | 12,560,028 | +1212% | 0.14% | $181,618,005 |
| GOLDMAN SACHS GROUP INC | 3.6% | 11,556,008 | +88% | 0.02% | $167,099,876 |
| Qube Research & Technologies Ltd | 2.8% | 8,809,340 | +99% | 0.18% | $127,383,056 |
| HBK INVESTMENTS L P | 2.8% | 8,783,448 | -42% | 1.6% | $127,008,658 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7% | 8,535,918 | +16% | 0.01% | $123,452,195 |
| O'Connor Alternative Investments LLC | 2.7% | 8,444,992 | 0% | 11% | $122,114,584 |
| MILLENNIUM MANAGEMENT LLC | 2.5% | 7,908,459 | +164% | 0.09% | $114,356,317 |
| MORGAN STANLEY | 2.2% | 6,998,884 | +28% | 0.01% | $101,203,875 |
| JPMORGAN CHASE & CO | 2.1% | 6,749,190 | +82% | 0.01% | $97,390,812 |
| AQR Arbitrage LLC | 1.8% | 5,843,849 | +195% | 1.4% | $84,502,057 |
| SOROS FUND MANAGEMENT LLC | 1.8% | 5,753,186 | +15% | 1.1% | $83,191,070 |
| Kryger Capital LLC | 1.4% | 4,554,174 | 0% | 4.7% | $65,853,356 |
| ALLIANCEBERNSTEIN L.P. | 1.4% | 4,316,272 | +59% | 0.02% | $61,463,713 |
| CITIGROUP INC | 1.3% | 4,226,882 | +156% | 0.04% | $61,120,714 |
| Magnetar Financial LLC | 1.3% | 3,986,058 | +0.46% | 0.59% | $57,638,399 |
| BANK OF AMERICA CORP /DE/ | 1.2% | 3,899,490 | +13% | 0% | $56,386,624 |
| Weiss Asset Management LP | 1.2% | 3,872,902 | +105% | 1% | $56,002,163 |
| Balyasny Asset Management L.P. | 1.2% | 3,827,513 | -25% | 0.11% | $55,345,838 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 331,789,683 | $4,794,109,165 | +$31,783,996 | $14.46 | 297 |
| 2025 Q4 | 321,103,533 | $4,570,432,958 | +$320,641,617 | $14.24 | 333 |
| 2025 Q3 | 312,179,498 | $2,460,108,114 | -$41,597,231 | $7.88 | 284 |
| 2025 Q2 | 319,344,550 | $1,830,820,509 | +$26,198,234 | $5.73 | 269 |
| 2025 Q1 | 309,423,212 | $2,526,512,925 | +$26,438,324 | $8.16 | 281 |
| 2024 Q4 | 305,140,281 | $2,874,465,217 | -$56,740,355 | $9.42 | 286 |
| 2024 Q3 | 309,836,000 | $3,309,105,094 | -$75,379,629 | $10.68 | 289 |
| 2024 Q2 | 315,168,068 | $3,126,533,611 | -$75,738,128 | $9.92 | 256 |
| 2024 Q1 | 321,847,405 | $3,791,483,281 | +$26,707,749 | $11.78 | 253 |
| 2023 Q4 | 318,908,725 | $4,524,863,003 | +$261,463,996 | $14.19 | 226 |
| 2023 Q3 | 298,862,861 | $3,633,462,965 | -$93,168,939 | $12.16 | 228 |
| 2023 Q2 | 307,102,100 | $3,857,183,589 | +$125,609,285 | $12.56 | 212 |
| 2023 Q1 | 297,533,564 | $3,299,196,032 | +$66,985,676 | $11.09 | 222 |
| 2022 Q4 | 292,444,452 | $3,570,548,028 | +$6,804,421 | $12.21 | 225 |
| 2022 Q3 | 292,887,704 | $3,053,948,950 | -$136,712,515 | $10.44 | 218 |
| 2022 Q2 | 305,130,656 | $3,277,204,978 | +$27,959,920 | $10.74 | 197 |
| 2022 Q1 | 303,248,438 | $2,872,272,289 | +$16,415,995 | $9.47 | 199 |
| 2021 Q4 | 301,421,729 | $3,479,958,222 | +$96,361,873 | $11.55 | 215 |
| 2021 Q3 | 292,731,132 | $2,798,448,068 | +$153,922,424 | $9.55 | 223 |
| 2021 Q2 | 276,914,599 | $2,669,802,857 | +$6,810,492 | $9.64 | 222 |
| 2021 Q1 | 275,685,202 | $2,723,386,669 | -$230,544,914 | $9.88 | 241 |
| 2020 Q4 | 279,155,505 | $6,445,326,162 | +$41,955,777 | $23.09 | 267 |
| 2020 Q3 | 277,950,423 | $3,923,978,054 | -$60,291,396 | $14.12 | 241 |
| 2020 Q2 | 281,585,235 | $4,247,304,450 | +$7,015,222 | $15.08 | 217 |
| 2020 Q1 | 283,489,123 | $2,618,877,274 | +$72,473,358 | $9.24 | 194 |